Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevention of mother-to-child transmission of HIV at the second immunization visit: a cross-sectional study, Burkina Faso.
Sakana BLD, Mennecier A, Fao P, Tassembedo S, Moles JP, Kania D, Taofiki AO, Kadeba FE, Diallo I, Eymard-Duvernay S, D'Ottavi M, Meda N, Mosqueira B, Van de Perre P, Nagot N; ANRS 12388 PREVENIR-PEV Study Group. Sakana BLD, et al. Among authors: kania d, d ottavi m. Bull World Health Organ. 2022 Dec 1;100(12):769-776. doi: 10.2471/BLT.22.288522. Epub 2022 Nov 1. Bull World Health Organ. 2022. PMID: 36466198 Free PMC article.
A new strategy to improve the cost-effectiveness of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis testing of blood donations in sub-Saharan Africa: a pilot study in Burkina Faso.
Kania D, Sangaré L, Sakandé J, Koanda A, Nébié YK, Zerbo O, Combasséré AW, Guissou IP, Rouet F. Kania D, et al. Transfusion. 2009 Oct;49(10):2237-40. doi: 10.1111/j.1537-2995.2009.02276.x. Epub 2009 Jul 6. Transfusion. 2009. PMID: 19903285
Low prevalence rate of indeterminate serological human immunodeficiency virus results among pregnant women from Burkina Faso, West Africa.
Kania D, Fao P, Valéa D, Gouem C, Kagoné T, Hien H, Somda P, Ouédraogo P, Drabo A, Gampini S, Méda N, Diagbouga S, Van de Perre P, Rouet F; WHO/ANRS 1289 Kesho Bora Study Group in Burkina Faso. Kania D, et al. J Clin Microbiol. 2010 Apr;48(4):1333-6. doi: 10.1128/JCM.01734-09. Epub 2010 Feb 3. J Clin Microbiol. 2010. PMID: 20129958 Free PMC article.
Maternal HIV-1 disease progression 18-24 months postdelivery according to antiretroviral prophylaxis regimen (triple-antiretroviral prophylaxis during pregnancy and breastfeeding vs zidovudine/single-dose nevirapine prophylaxis): The Kesho Bora randomized controlled trial.
Kesho Bora Study Group. Kesho Bora Study Group. Clin Infect Dis. 2012 Aug;55(3):449-60. doi: 10.1093/cid/cis461. Epub 2012 May 9. Clin Infect Dis. 2012. PMID: 22573845 Free PMC article. Clinical Trial.
117 results